Antibody against a complex between human GARP and latent TGF-β
US10604579B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 9, 2018 |
| Grant date | Mar 31, 2020 |
| Priority date | — |
| Expiry date | May 9, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a protein binding to GARP in the presence of TGF-β and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.